April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Role Of Lentivirus-Mediated Overexpression Of Programmed Death Ligand-1 On Corneal Allograft Survival
Author Affiliations & Notes
  • Thomas Ritter
    Medicine, Nt'l Univ of Ireland, Galway, Galway, Ireland
  • Mieszko Wilk
    Medicine, Nt'l Univ of Ireland, Galway, Galway, Ireland
  • Mourice Morcos
    Medicine, Nt'l Univ of Ireland, Galway, Galway, Ireland
  • Marese Cregg
    Medicine, Nt'l Univ of Ireland, Galway, Galway, Ireland
  • O'Flynn Lisa
    Medicine, Nt'l Univ of Ireland, Galway, Galway, Ireland
  • Oliver Treacy
    Medicine, Nt'l Univ of Ireland, Galway, Galway, Ireland
  • Mikhail Nosov
    Medicine, Nt'l Univ of Ireland, Galway, Galway, Ireland
  • Footnotes
    Commercial Relationships  Thomas Ritter, None; Mieszko Wilk, None; Mourice Morcos, None; Marese Cregg, None; O'Flynn Lisa, None; Oliver Treacy, None; Mikhail Nosov, None
  • Footnotes
    Support  Science Foundation Ireland (SFI) Principal Investigator Grant No 07/IN.1/B925
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3008. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Thomas Ritter, Mieszko Wilk, Mourice Morcos, Marese Cregg, O'Flynn Lisa, Oliver Treacy, Mikhail Nosov; Role Of Lentivirus-Mediated Overexpression Of Programmed Death Ligand-1 On Corneal Allograft Survival. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3008.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the role of lentivirus-mediated overexpression of Programmed Death Ligand-1 (PDL-1) on rat corneal allograft survival.

Methods: : Lentivirus (LV) encoding for PDL-1 (LV.PDL-1) and EGFP (LV.EGFP, as control) were constructed and tested in vitro for mRNA and protein expression by real-time RT-PCR and flow cytometry. A fully allogeneic rat cornea transplant model (DA to LEW) was used for in vivo studies. Ex-vivo cultured corneas from DA rats were transduced with LV.PDL-1 and LV.EGFP and transplanted into LEW recipients. Graft survival and neovascularization was monitored and immunohistochemistry was used to analyze lymphocyte infiltration in the cornea. Moreover, flow cytometric analysis of collagenase digested corneas and draining lymph nodes was applied to study immune cell distribution and function in allo-transplanted animals.

Results: : LV.PDL-1 and LV.EGFP were routinely produced in high titers. An increase of EGFP expression was observed after LV.EGFP transduction for 1, 4 and 20h of incubation of cultured corneas. PDL-1 expression was increased on corneal cells upon LV.PDL-1 transduction compared to vector-treated corneas. In vivo untreated allogeneic controls and allogeneic LV.EGFP transduced corneas were uniformly rejected (MST 13.8±1.7d, n=11 and 12.3±1.9d, n=4, respectively). In contrast, allogeneic LV.PDL-1 transduced corneas showed a high percentage (83%) of graft survival (MST >30d, n=5, 15d, n=1). Interestingly, the dynamics of opacity score close to expected rejection time was similar for LV.PDL-1 and LV.GFP treated groups which assumes that over-expression of PDL-1 does not protect the cornea from lymphocyte infiltration but rather from rejection. Time point analysis revealed reduced expression of pro-inflammatory cytokines (IFN-γ) by infiltrating lymphocytes in PDL-1 transduced corneas compared to allogeneic controls.

Conclusions: : Lentiviral vectors are efficient tools for ex vivo genetic modification of cultured corneas. Local PDL-1 gene transfer is a promising approach for the prevention of corneal allograft rejection.

Keywords: transplantation • immunomodulation/immunoregulation • gene transfer/gene therapy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×